Mutation rates in humans. II. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B.
We estimated the rates per base per generation of specific types of mutations, using our direct estimate of the overall mutation rate for hemophilia B and information on the mutations present in the United Kingdom's population as well as those reported year by year in the hemophilia B world database. These rates are as follows: transitions at CpG sites 9.7x10-8, other transitions 7.3x10-9, transversions at CpG sites 5.4x10-9, other transversions 6.9x10-9, and small deletions/insertions causing frameshifts 3.2x10-10. By taking into account the ratio of male to female mutation rates, the above figures were converted into rates appropriate for autosomal DNA-namely, 1.3x10-7, 9.9x10-9, 7.3x10-9, 9.4x10-9, 6.5x10-10, where the latter is the rate for all small deletion/insertion events. Mutation rates were also independently estimated from the sequence divergence observed in randomly chosen sequences from the human and chimpanzee X and Y chromosomes. These estimates were highly compatible with those obtained from hemophilia B and showed higher mutation rates in the male, but they showed no evidence for a significant excess of transitions at CpG sites in the spectrum of Y-sequence divergence relative to that of X-chromosome divergence. Our data suggest an overall mutation rate of 2.14x10-8 per base per generation, or 128 mutations per human zygote. Since the effective target for hemophilia B mutations is only 1.05% of the factor IX gene, the rate of detrimental mutations, per human zygote, suggested by the hemophilia data is approximately 1.3.
Giannelli
F
F
Division of Medical and Molecular Genetics, Guy's, King's, and St. Thomas' School of Medicine, Guy's Campus, London SE1 9RT, United Kingdom. francesco.giannelli@kcl.ac.uk.
Anagnostopoulos
T
T
Green
P M
PM
D000818:Animals; D018899:CpG Islands / Q000235:genetics; D004252:DNA Mutational Analysis; D016208:Databases, Factual; D019143:Evolution, Molecular; D005164:Factor IX / Q000235:genetics; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D015894:Genome, Human; D002836:Hemophilia B / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics*; D002679:Pan troglodytes / Q000235:genetics; D010641:Phenotype; D012727:Sex Characteristics; D006113:United Kingdom; D014960:X Chromosome / Q000235:genetics; D014998:Y Chromosome / Q000235:genetics; D015053:Zygote / Q000378:metabolism
D005164:Factor IX